These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6317115

  • 21. Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine.
    Brandão F, Monteiro JG, Osswald W.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):37-40. PubMed ID: 723969
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Transmitter release modulated by alpha-adrenoceptor antagonists in the rabbit mesenteric artery: a comparison between noradrenaline outflow and electrical activity.
    Mishima S, Miyahara H, Suzuki H.
    Br J Pharmacol; 1984 Oct; 83(2):537-47. PubMed ID: 6148987
    [Abstract] [Full Text] [Related]

  • 24. A kinetic study of the release of noradrenaline by electrical stimulation: influence of presynaptic alpha-adrenoceptors.
    Brandão F, Davidson R, Monteiro JG.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):248-52. PubMed ID: 2984584
    [Abstract] [Full Text] [Related]

  • 25. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ, Vanhoutte PM.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [Abstract] [Full Text] [Related]

  • 26. Oxidative deamination of noradrenaline in human blood vessels.
    Osswald W.
    J Neural Transm Suppl; 1990 Feb; 32():395-404. PubMed ID: 2089103
    [Abstract] [Full Text] [Related]

  • 27. Effects of estradiol on release and disposition of norepinephrine from nerve endings.
    Hamlet MA, Rorie DK, Tyce GM.
    Am J Physiol; 1980 Oct; 239(4):H450-H456. PubMed ID: 6252789
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role played by the extraneuronal system in the disposition of noradrenaline and adrenaline in vessels.
    Guimarães S, Paiva MQ.
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):279-87. PubMed ID: 840321
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Tissue accumulation and release of newly synthesized 3H-dopamine and 3H-noradrenaline in canine saphenous veins incubated with 3H-(--)-tyrosine.
    Boels PJ, Verbeuren TJ, Vanhoutte PM.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):7-14. PubMed ID: 6633679
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.
    Hughes J.
    Br J Pharmacol; 1972 Mar; 44(3):472-91. PubMed ID: 4339251
    [Abstract] [Full Text] [Related]

  • 34. Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.
    Muldoon SM, Vanhoutte PM, Tyce GM.
    Am J Physiol; 1978 Mar; 234(3):H235-43. PubMed ID: 629360
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of a haloalkylamine on responses to and disposition of sympathomimetic amines.
    Kalsner S, Nickerson M.
    Br J Pharmacol; 1969 Mar; 35(3):440-55. PubMed ID: 5809736
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Extraneuronal uptake of noradrenaline in human tissue (uptake2).
    Babin-Ebell J, Gliese M.
    Heart Vessels; 1995 Mar; 10(3):151-3. PubMed ID: 7673085
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.